Skip to main content
NIH funding notice PAR-23-154

Development and Validation of Models for Alzheimers Disease-Related Dementias (ADRD) (R61/R33 - Clinical Trial Not Allowed)

Closed on October 20, 2023.

Posted
April 11, 2023
Close date
October 20, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,313,655 in first-year total cost, median $1,698,323.

Most frequent study sections

  1. Special Emphasis Panel[ZNS1 SRB-M (19)]2
  2. Special Emphasis Panel[ZNS1 SRB-M (17)]1

Most frequent institutions

  1. REGENERATIVE RESEARCH FOUNDATION1
  2. SEATTLE CHILDREN'S HOSPITAL1
  3. UNIVERSITY OF CALIFORNIA, SAN DIEGO1
Competing awards under PAR-23-154 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2024Human iPSC model of Cerebro-Vascular Interactions in ADRD1R61NS138655-01TEMPLE, SALLYREGENERATIVE RESEARCH FOUNDATION, NY$1,931,965ZNS1
2024Develop and Validate a Mouse Model for Alzheimer Disease in Down Syndrome1R61NS138830-01MOBLEY, WILLIAM CUNIVERSITY OF CALIFORNIA, SAN DIEGO, CA$1,698,323ZNS1
2024Chemogenetic Mouse Models for Cerebral Hypoperfusion and VCID1R61NS137365-01SHIH, ANDY YZHAO, ZHENSEATTLE CHILDREN'S HOSPITAL, WA$683,367ZNS1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.